Physician profile
Scott Baker
NPI 1356316053
$8,833.61
in general payments reported to CMS, 2019-2025
15 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,031 · 2020: $226 · 2021: $1,277 · 2022: $3,214 · 2023: $75.69 · 2024: $1,678 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440 · Travel and Lodging: $630 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.54 |
| Travel and Lodging | $630.43 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,451.47 | 2019-2025 | |
| Ethicon US, LLC | $65.02 | 2021-2024 | Dermabond Prineo, Dermabond, Monocryl |
| Medtronic, INC. | $56.85 | 2025 | Transorb |
| Tela Bio, INC. | $55.24 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Organogenesis INC. | $30.31 | 2022 | |
| Integra Lifesciences Corporation | $25.73 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.38 | 2019 | |
| Sumitomo Pharma America, INC. | $19.01 | 2024 | Orgovyx |
| Boston Scientific Corporation | $18.43 | 2021 | |
| Davol INC. | $17.20 | 2025 | Phasix Mesh |
| Janssen Pharmaceuticals, INC | $16.18 | 2023 | Xarelto |
| Conmed Corporation | $15.05 | 2024 | Airseal |
| Kci USA, INC. | $14.88 | 2023 | Prevena, Abthera |
| Solventum Corporation | $14.45 | 2024 | Prevena, V.A.C.Ulta |
| Neurelis, INC. | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.